DAYNA STATES: Open Payments
NPI 1235756230 · PERKASIE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$457 in 24 payments from 13 companies in 2025. Trend: 2023 $499 · 2024 $478 · 2025 $457
Food & beverage: $457
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 6 | $116 |
| Astellas Pharma US Inc | 2 | $50 |
| Novo Nordisk Inc | 2 | $39 |
| GlaxoSmithKline, LLC. | 2 | $38 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $37 |
| PFIZER INC. | 2 | $37 |
| Lilly USA, LLC | 2 | $35 |
| Inspire Medical Systems, Inc. | 1 | $25 |
| AstraZeneca Pharmaceuticals LP | 1 | $18 |
| Kowa Pharmaceuticals America, Inc. | 1 | $17 |
Products named: VRAYLAR, Veozah, Wegovy, SHINGRIX, XIFAXAN, INSPIRE, PREVNAR 20, QULIPTA.
Industry payments across PA — which companies pay providers there.
